Literature DB >> 6758181

A unique pathway for the plasma elimination of alpha 2-antiplasmin-protease complexes in mice.

S L Gonias, H E Fuchs, S V Pizzo.   

Abstract

Radiolabeled alpha 2-antiplasmin cleared slowly from the circulation of mice. Complex formation with either plasmin or trypsin resulted in a significant increase in the plasma elimination rate of the protease inhibitor. Approximately 20 min and 14 min were required for 50% of the injected alpha 2-antiplasmin-plasmin and alpha 2-antiplasmin-trypsin to clear from the circulation, respectively. Significant competition was observed when radiolabeled alpha 2-antiplasmin-plasmin was cleared in the presence of a large molar excess of unlabeled alpha 2-antiplasmin-plasmin. alpha 1-Antitrypsin-trypsin failed to complete with radiolabeled alpha 2-antiplasmin-plasmin even when present at 2000 fold molar excess. Organ distribution studies localized the major site of alpha 2-antiplasmin-plasmin clearance in the liver. Microscopic autoradiography data suggested that the cell responsible for the clearance pathway was the hepatocyte.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6758181

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Alpha 2-macroglobulin is the primary inhibitor of miniplasmin in vitro and in vivo in the mouse. Comparison with alpha 2-antiplasmin in simultaneous reaction experiments.

Authors:  S L Gonias; N L Figler
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

2.  Assignment of a single disulphide bridge in human alpha2-antiplasmin: implications for the structural and functional properties.

Authors:  S Christensen; Z Valnickova; I B Thogersen; E H Olsen; J J Enghild
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis.

Authors:  Alban Gaultier; Xiaohua Wu; Natacha Le Moan; Shinako Takimoto; Gatambwa Mukandala; Katerina Akassoglou; W Marie Campana; Steven L Gonias
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

4.  Human plasma kallikrein and C1 inhibitor form a complex possessing an epitope that is not detectable on the parent molecules: demonstration using a monoclonal antibody.

Authors:  A de Agostini; M Schapira; Y T Wachtfogel; R W Colman; S Carrel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

5.  A nonantigenic covalent streptokinase-polyethylene glycol complex with plasminogen activator function.

Authors:  S Rajagopalan; S L Gonias; S V Pizzo
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.

Authors:  A de Agostini; P A Patston; V Marottoli; S Carrel; P C Harpel; M Schapira
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

7.  Time-delimited signaling of MET receptor tyrosine kinase regulates cortical circuit development and critical period plasticity.

Authors:  Ke Chen; Xiaokuang Ma; Antoine Nehme; Jing Wei; Yan Cui; Yuehua Cui; Dezhong Yao; Jie Wu; Trent Anderson; Deveroux Ferguson; Pat Levitt; Shenfeng Qiu
Journal:  Mol Psychiatry       Date:  2020-01-03       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.